The Role of Fibroblast Activation Protein Inhibitor Positron Emission Tomography in Inflammatory and Infectious Diseases: An Updated Systematic Review

Domenico Albano, Alessio Rizzo, Riemer H J A Slart, Søren Hess, Edel Noriega-Álvarez, Cristina Gamila […]

2024-09-04T13:59:05+00:00May 31st, 2024|Publications|

[18F]FAPI-74 serving as complementary diagnostic in Avacta Phase 1 trial

May 23, 2024 – SOFIE is pleased to partner with Avacta through Avacta’s use […]

2024-06-03T20:17:45+00:00May 23rd, 2024|News|

[68Ga]Ga-FAPI-46 PET/CT for penile cancer – a feasibility study

Lennert Eismann, Stephan T Ledderose, Benazir Enzinger, Elena Berg, Thilo Westhofen, Severin Rodler, Gerald B […]

2024-06-03T17:14:58+00:00May 18th, 2024|Publications|

68Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy

Helena Lanzafame, Ilektra A Mavroeidi, Kim M Pabst, Mélanie Desaulniers, Marc Ingenwerth, Nader Hirmas, Lukas […]

2024-06-03T18:27:17+00:00May 9th, 2024|Publications|

A Systematic Review on the Diagnostic Value of Fibroblast Activation Protein Inhibitor PET/CT in Genitourinary Cancers

Marinus J Hagens, Pim J van Leeuwen, Maurits Wondergem, Thierry N Boellaard, Francesco Sanguedolce, Daniela […]

2024-06-03T18:36:24+00:00April 18th, 2024|Publications|

Highlights of the 36th EANM Annual Congress 2023, from hometown Vienna, Austria: “A SYMPHONY OF SCIENCE”

David Kersting, Silvia Morbelli, Sophie E. M. Veldhuijzen van Zanten & Hein J. Verberne

2024-04-11T16:58:33+00:00April 4th, 2024|Publications|

Focus on FAPI Newsletter – Winter 2024

A WORD FROM OUR CHIEF SCIENTIFIC OFFICER

Dear FAPI Community,

We are looking forward to a […]

2024-03-13T16:40:34+00:00March 12th, 2024|Newsletter|

Fibroblast Activation Protein α-Directed Imaging and Therapy of Solitary Fibrous Tumor

Rainer Hamacher, Kim M Pabst, Phyllis F Cheung, Christoph E Heilig, Jennifer Hüllein, Sven-Thorsten Liffers, […]

2024-03-12T01:24:56+00:00February 18th, 2024|Publications|

18F-FAPI-04 Outperforms 18F-FDG PET/CT in Clinical Assessments of Patients with Pancreatic Adenocarcinoma

Xiang Li, Na Lu, Lili Lin, Yiwen Chen, Shuye Yang, Huatao Wang, Xinyuan Liu, Chengyi […]

2024-03-12T01:18:36+00:00February 12th, 2024|Publications|

Focus on FAPI Newsletter – Fall 2023

A WORD FROM OUR CHIEF SCIENTIFIC OFFICER

2023-12-11T00:05:30+00:00December 6th, 2023|Newsletter|
Go to Top